ClinicalTrials.gg

Celltrion clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 84 studies whose lead sponsor is Celltrion or one of 2 companies grouped under it. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 27, 2026.

Our grouping of 3 registry names, not the registry’s. See them and correct one ↓

Compare Celltrion with Johnson & Johnson and Takeda →

Pipeline: 15 programs

Each counted once: 15 with a study Celltrion leads registered in the last two years.

  • Phase 1
  • Phase 3

The 5 of 9 with the most live studies.

Program
CT-P55Phase 3 · 1 live · Psoriasis☆ Track
CT-P51Phase 3 · 1 live · Carcinoma, Non-Small-Cell Lung · primary completion Feb 2027☆ Track
daratumumabPhase 3 · 1 live · Multiple Myeloma · primary completion Mar 2027☆ Track
empagliflozinPhase 3 · 1 live · Diabetes Mellitus, Type 2 · primary completion Dec 2026☆ Track
CT-P43Phase 3 · 0 live · Psoriasis☆ Track

4 more in phase 3 — sign in to see them all, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Celltrion’s own registered studies; Celltrion’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Celltrion’s studies test, most open studies first — 25 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 15 more

Coming up

6 of Celltrion’s studies under way reach primary completion within a year, 4 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. 2F
  5. 2M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add all 6 to your calendar (.ics) → With an account.

All 84 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now45%
  • Under way, not recruiting56%
  • Completed6476%
  • Stopped early78%Terminated 6 · Withdrawn 1
  • Status unknown or other45%

Phase

  • Phase 139
  • Phase 333
  • Phase 24
  • Phase 41

Where

  • Korea, Republic of46
  • Poland12
  • France6
  • United States6
  • Japan3
  • Ukraine3

Over the years

  1. 10
  2. 11
  3. 12
  4. 13
  5. 14
  6. 15
  7. 16
  8. 17
  9. 18
  10. 19
  11. 20
  12. 21
  13. 1222
  14. 23
  15. 24
  16. 25
  17. 226

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Celltrion.

  • Celltrion
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    77 studies
  • Celltrion Pharm, Inc.
    Acquired — became part of Celltrion, 2014 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    4 studies →
  • Celltrion HealthCare France
    Acquired — became part of Celltrion, Dec 28, 2023 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    3 studies →

Focus areas

Conditions Celltrion leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 84. Browse all 84 →